News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,382 Results
Type
Article (61148)
Company Profile (487)
Press Release (690747)
Section
Business (210817)
Career Advice (3296)
Deals (36287)
Drug Delivery (126)
Drug Development (85169)
Employer Resources (184)
FDA (17411)
Job Trends (15876)
News (360512)
Policy (36015)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (11)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (9)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (11)
2024 Pharm Country Digital (9)
2024 Pharm Country Standard (7)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2921)
Academic (2)
Accelerated approval (3)
Adcomms (29)
Allergies (87)
Alliances (53549)
ALS (89)
Alzheimer's disease (1448)
Antibody-drug conjugate (ADC) (133)
Approvals (17378)
Artificial intelligence (268)
Autoimmune disease (19)
Automation (14)
Bankruptcy (350)
Best Places to Work (12454)
BIOSECURE Act (19)
Biosimilars (113)
Biotechnology (357)
Bladder cancer (63)
Brain cancer (28)
Breast cancer (264)
Cancer (2094)
Cardiovascular disease (172)
Career advice (2786)
Career pathing (33)
CAR-T (160)
Cell therapy (449)
Cervical cancer (19)
Clinical research (68524)
Collaboration (822)
Compensation (442)
Complete response letters (29)
COVID-19 (2815)
CRISPR (42)
C-suite (222)
Cystic fibrosis (105)
Data (1951)
Decentralized trials (2)
Denatured (43)
Depression (46)
Diabetes (264)
Diagnostics (6709)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (119)
Drug shortages (33)
Duchenne muscular dystrophy (91)
Earnings (84463)
Editorial (39)
Employer branding (23)
Employer resources (160)
Events (122594)
Executive appointments (664)
FDA (18553)
Featured Employer (62)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (737)
Gene editing (107)
Generative AI (27)
Gene therapy (318)
GLP-1 (800)
Government (5008)
Grass and pollen (4)
Guidances (48)
Healthcare (20466)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (125)
Indications (27)
Infectious disease (2954)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (86)
Interviews (639)
IPO (16804)
IRA (49)
Job creations (3927)
Job search strategy (2286)
Kidney cancer (10)
Labor market (32)
Layoffs (509)
Leadership (20)
Legal (8489)
Liver cancer (76)
Lung cancer (307)
Lymphoma (133)
Machine learning (2)
Management (64)
Manufacturing (300)
MASH (66)
Medical device (14200)
Medtech (14205)
Mergers & acquisitions (19983)
Metabolic disorders (710)
Multiple sclerosis (74)
NASH (22)
Neurodegenerative disease (96)
Neuropsychiatric disorders (30)
Neuroscience (1964)
NextGen: Class of 2025 (7361)
Non-profit (4883)
Northern California (2433)
Now hiring (34)
Obesity (390)
Opinion (267)
Ovarian cancer (73)
Pain (87)
Pancreatic cancer (76)
Parkinson's disease (140)
Partnered (19)
Patents (214)
Patient recruitment (96)
Peanut (51)
People (59802)
Pharmaceutical (99)
Pharmacy benefit managers (21)
Phase I (21270)
Phase II (29954)
Phase III (22718)
Pipeline (1006)
Podcasts (118)
Policy (129)
Postmarket research (2903)
Preclinical (9194)
Press Release (72)
Prostate cancer (96)
Psychedelics (37)
Radiopharmaceuticals (267)
Rare diseases (398)
Real estate (6373)
Recruiting (73)
Regulatory (24626)
Reports (40)
Research institute (2596)
Resumes & cover letters (521)
Rett syndrome (3)
RNA editing (2)
RSV (45)
Schizophrenia (74)
Series A (132)
Series B (83)
Service/supplier (13)
Sickle cell disease (55)
Southern California (2110)
Special edition (18)
Spinal muscular atrophy (161)
Sponsored (33)
Startups (3829)
State (2)
Stomach cancer (15)
Supply chain (65)
The Weekly (72)
United States (21944)
Vaccines (744)
Venture capitalists (39)
Webinars (12)
Weight loss (285)
Women's health (38)
Worklife (18)
Date
Today (16)
Last 7 days (577)
Last 30 days (2563)
Last 365 days (35632)
2025 (8203)
2024 (37426)
2023 (42157)
2022 (53478)
2021 (58213)
2020 (57002)
2019 (50338)
2018 (38220)
2017 (35427)
2016 (35649)
2015 (41326)
2014 (34575)
2013 (30110)
2012 (31928)
2011 (31989)
2010 (29919)
Location
Africa (1025)
Alabama (55)
Alaska (7)
Arizona (211)
Arkansas (14)
Asia (44426)
Australia (7521)
California (5638)
Canada (1885)
China (496)
Colorado (256)
Connecticut (278)
Delaware (130)
Europe (101760)
Florida (828)
Georgia (201)
Hawaii (1)
Idaho (62)
Illinois (560)
India (26)
Indiana (307)
Iowa (10)
Japan (142)
Kansas (103)
Kentucky (26)
Louisiana (10)
Maine (68)
Maryland (882)
Massachusetts (4377)
Michigan (231)
Minnesota (382)
Mississippi (2)
Missouri (84)
Montana (29)
Nebraska (26)
Nevada (57)
New Hampshire (69)
New Jersey (1618)
New Mexico (31)
New York (1614)
North Carolina (1035)
North Dakota (8)
Northern California (2433)
Ohio (203)
Oklahoma (15)
Oregon (37)
Pennsylvania (1262)
Puerto Rico (10)
Rhode Island (27)
South America (1385)
South Carolina (19)
South Dakota (1)
Southern California (2110)
Tennessee (93)
Texas (826)
Utah (173)
Virginia (139)
Washington D.C. (61)
Washington State (540)
West Virginia (3)
Wisconsin (54)
752,382 Results for "the medicines and healthcare products regulatory agency mhra".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)
March 11, 2025
·
3 min read
Press Releases
OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma
March 11, 2025
·
4 min read
Press Releases
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
February 28, 2025
·
4 min read
Press Releases
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
March 26, 2025
·
8 min read
Press Releases
UK Medicines and Healthcare Products Regulatory Agency has Validated and Accepted the Marketing Authorization Application for ADL-018, a Proposed Biosimilar of Xolair® (omalizumab)
March 27, 2025
·
2 min read
Press Releases
ImmunityBio Announces UK Medicines and Healthcare Products Regulatory Agency Accepted Marketing Authorization Application for ANKTIVA® for the Treatment of Patients with BCG-unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In Situ
February 14, 2025
·
9 min read
Press Releases
Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1
September 3, 2024
·
4 min read
Biotech Beach
Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain
Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group), today announced The Medicines and Healthcare products Regulatory Agency (MHRA) authorization of NULIBRY.
April 16, 2024
·
6 min read
GLP-1
UK’s MHRA Finds No Risk of Suicidal Ideation, Self-Harm With GLP-1 Drugs
Like its U.S. and European counterparts, Britain’s Medicines and Healthcare Products Regulatory Agency found no conclusive link between the use of GLP-1s and a heightened risk of suicidal and self-injury thoughts.
September 5, 2024
·
2 min read
·
Tristan Manalac
Biotech Beach
Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults
Cidara Therapeutics, Inc. (Nasdaq: CDTX) today announced that the United Kingdom (U.K.) Medicines and Healthcare products Regulatory Agency (MHRA) has approved REZZAYO (rezafungin acetate) for the treatment of invasive candidiasis in adults.
January 29, 2024
·
5 min read
1 of 75,239
Next
